Gemini Therapeutics, Inc.
(NASDAQ GM: GMTX)
Rigrodsky Law, P.A. is investigating Gemini Therapeutics, Inc. (“Gemini”) regarding possible breaches of fiduciary duties and other violations of law related to Gemini’s agreement to acquire Disc Medicine, Inc. Under the terms of the agreement, Gemini shareholders are expected to own approximately 28% of the combined company.